chlormadinone acetate has been researched along with Prostatic Hyperplasia in 67 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (20.90) | 18.7374 |
| 1990's | 32 (47.76) | 18.2507 |
| 2000's | 15 (22.39) | 29.6817 |
| 2010's | 5 (7.46) | 24.3611 |
| 2020's | 1 (1.49) | 2.80 |
| Authors | Studies |
|---|---|
| Bedin, S; Contiero, B; Ferré-Dolcet, L; Frigotto, L; Romagnoli, S | 1 |
| Janowski, T; Socha, P; Tobolski, D; Zduńczyk, S | 1 |
| Barbon, AR; Glendewar, G; Haworth, P; Ordóñez, IA; Pocknell, A; Routh, A | 1 |
| Güssow, A; Kempker, K; Neiger, R | 1 |
| Arai, S; Ito, K; Koike, H; Matsui, H; Miyazawa, Y; Nomura, M; Sekine, Y; Shibata, Y; Shuto, T; Suzuki, K | 1 |
| Albouy, M; Eun, HM; Maynard, L; Sanquer, A | 1 |
| Boku, E; Fuji, K; Fujimoto, K; Furuya, R; Hirao, Y; Miyazawa, K; Nagata, M; Ohashi, Y; Ohtani, N; Shibata, Y; Shimizu, N; Tsuji, H | 1 |
| Araki, T; Furuya, R; Furuya, S; Ogura, H; Shimamura, S | 1 |
| Kanazawa, M; Kawauchi, A; Kojima, M; Miki, T; Miyashita, H; Nakanouchi, T; Ukimura, O; Yoneda, K | 1 |
| Arai, Y; Fujimoto, K; Hirao, Y; Kato, T; Masumori, N; Miyazawa, K; Yamanaka, H | 1 |
| Matsumoto, M; Shimizu, J; Yamazaki, E; Yasue, M | 1 |
| Kodama, T; Shimazaki, J; Wakisaka, M | 1 |
| Shida, K | 1 |
| Fujii, M; Fujisawa, S; Kamiryo, Y; Koshito, K; Yasui, H | 1 |
| Haraguchi, C; Higaki, Y; Imamura, K; Kawai, N; Ogawa, Y; Ohyama, M; Saitoh, T; Yoshida, H | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Ito, K; Kushitani, M; Mieda, M; Suzuki, K; Takezawa, Y; Yamanaka, H | 1 |
| Hasegawa, F; Isurugi, K; Takahashi, S | 1 |
| Iguchi, H; Ikeuchi, T; Kai, Y; Yoshida, H | 1 |
| Harada, M; Hosaka, M; Kinoshita, Y; Kondo, I; Kumagai, H; Moriyama, M; Nakahashi, M; Sasaki, K | 1 |
| Inada, R; Mizokami, A; Murakoshi, M; Suzuki, M; Tagawa, M; Watanabe, K | 1 |
| Kishimoto, T; Maekawa, T; Nakatani, T; Nishisaka, N; Wada, S; Yamamoto, K; Yasumoto, R | 1 |
| Aoki, H; Aoki, M; Arai, Y; Komatsu, Y; Kubo, T; Kumamoto, Y; Sato, Y; Tsukamoto, T; Umehara, T; Yoshida, O | 1 |
| Akiyama, T; Kaneko, S; Kurita, T; Mizunaga, M; Park, YC; Yachiku, S | 1 |
| Kawakami, E; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T | 1 |
| Arai, Y; Oishi, K; Onishi, H; Takeuchi, H; Terai, A; Yoshida, O | 1 |
| Fujita, M; Hori, T; Kawakami, E; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T | 1 |
| Higashino, I; Kido, K; Kogawa, T; Kudo, T; Mikuni, T; Suzuki, T; Takashima, T; Tsukui, A; Yagihashi, Y; Yanagiya, H | 1 |
| Kawakami, E; Makanae, Y; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T; Yajima, K | 1 |
| Fujita, M; Kawakami, E; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T | 1 |
| Hibi, H; Miyake, K; Yamamoto, M | 1 |
| Arakawa, S; Kamidono, S; Kawaida, N; Matsumoto, O; Ogawa, T; Okada, H | 1 |
| Fujita, M; Hori, T; Kawakami, E; Orima, H; Shimizu, M; Tsutsui, T | 1 |
| Church, DB; Court, EA; Emslie, DR; Watson, AD | 1 |
| Akakura, K; Furuya, Y; Ito, H | 1 |
| Asari, T; Egawa, M; Haginaka, T; Kameda, K; Katsumi, T; Kawaguchi, K; Miyazaki, K; Murayama, K; Nishino, A; Sakai, A; Ueki, O | 1 |
| Honma, S; Ikeda, R; Mieda, M; Murakoshi, M; Nakayama, T; Tagawa, M | 1 |
| Honma, S; Ikeda, R; Masuda, S; Mieda, M; Murakoshi, M; Nakayama, T; Tagawa, M | 1 |
| Ikeda, R; Murakoshi, M; Nakayama, T; Tagawa, M | 1 |
| Ikeda, R; Murakoshi, M; Tagawa, M | 1 |
| Fukabori, Y; Gotanda, K; Honma, S; Ito, K; Mieda, M; Shibata, Y; Suzuki, K; Yamanaka, H | 1 |
| Ikada, R; Murakoshi, M; Nakayama, T; Tagawa, M | 1 |
| Fukuda, S; Hori, T; Kawakami, E; Orima, H; Shimizu, M; Tsutsu, T | 1 |
| Hosaka, M; Noguchi, K; Ogawa, K; Sekiguchi, Y; Takeda, M; Uemura, H | 1 |
| Fukabori, Y; Ito, K; Shibata, Y; Suzuki, K; Yamanaka, H | 1 |
| Akaza, H; Kikuchi, K; Koiso, K; Kondo, F; Noguchi, R; Ohtani, M; Tsuchiya, A | 1 |
| Hori, T; Kawakami, E; Shimizu, M; Tatsuzawa, C; Tsutsui, T | 1 |
| Fukui, N; Ikeda, R; Murakoshi, M | 1 |
| Fukui, N; Ikeda, R; Murakoshi, M; Nakayama, T | 1 |
| Imai, K; Ito, Y; Koya, A; Kurosawa, I; Yamanaka, H | 1 |
| Kondo, A; Sato, S; Shida, K; Shimazaki, J; Takai, S | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Kushitani, M; Mieda, M; Takezawa, Y; Yamanaka, H | 1 |
| Honma, S; Inada, R; Makino, M; Mieda, M; Murakoshi, M; Suzuki, M; Tagawa, M; Takezawa, Y; Yamanaka, H | 1 |
| Kadono, M; Kato, S; Kumamoto, Y; Maki, A; Matsumoto, H; Mori, K; Sato, Y; Suzuki, R; Tanda, H; Yamaguchi, Y | 2 |
| Hashimoto, K; Ichinose, Y; Imai, K; Matsumoto, K; Suzuki, K; Suzuki, T; Yamanaka, H | 1 |
| Fuse, H; Ishikawa, S; Katayama, T; Kazama, T; Mizuno, I; Takamine, T; Terada, T; Umeda, K | 1 |
| Honma, S; Inada, R; Makino, M; Mieda, M; Murakoshi, M; Suzuki, M; Yamanaka, H | 1 |
| Kanimoto, Y; Okada, K | 1 |
| Umeda, K | 1 |
| Kawakura, K; Koyanagi, T; Kumamoto, Y; Nishida, T; Orikasa, S; Sato, S; Shida, K; Shimazaki, J; Takeda, M; Yamanaka, H | 1 |
| Higuchi, T; Kimura, A | 1 |
| Neumann, F; Steinbeck, H | 1 |
| Vernet, D | 1 |
| Kurihara, H; Shida, K; Shimazaki, J; Takahashi, H; Urano, E | 1 |
| Ito, Z; Shida, K; Shinozaki, T | 1 |
| Fruchtman, B; Geller, J; Meyer, C; Newman, H | 1 |
| Angrist, A; Geller, J; Nakao, K; Newman, H | 1 |
5 review(s) available for chlormadinone acetate and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Transurethral resection for prostatic adenoma larger than 100 ml--preoperative treatment with interstitial laser coagulation of the prostate plus chlormadinone acetate as a treatment maneuver for safer operations].
Topics: Aged; Chlormadinone Acetate; Humans; Laser Coagulation; Male; Middle Aged; Preoperative Care; Prostate; Prostatic Hyperplasia; Transurethral Resection of Prostate | 2005 |
[Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
Topics: Aged; Androgen Antagonists; Animals; Chlormadinone Acetate; Clinical Trials as Topic; Humans; Hydroxytestosterones; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats | 1980 |
[Application of antiandrogens on prostatic diseases].
Topics: Androgen Antagonists; Chlormadinone Acetate; Clinical Trials as Topic; Flutamide; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms | 1994 |
[Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
Topics: Androgen Antagonists; Anilides; Chlormadinone Acetate; Flutamide; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Tosyl Compounds | 1998 |
[Anti-androgens. Animal experiments and clinical application].
Topics: Acetates; Androgen Antagonists; Animals; Bone and Bones; Chlormadinone Acetate; Disorders of Sex Development; Dogs; Feedback; Female; Fertility; Humans; Hydroxyprogesterones; Libido; Male; Mice; Progestins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Drug; Sebaceous Glands; Spermatozoa | 1971 |
16 trial(s) available for chlormadinone acetate and Prostatic Hyperplasia
| Article | Year |
|---|---|
The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Male; Prostate; Prostatic Hyperplasia | 2018 |
Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Drug Administration Schedule; Male; Prostatic Hyperplasia | 2008 |
[Transurethral resection for prostatic adenoma larger than 100 ml--preoperative treatment with interstitial laser coagulation of the prostate plus chlormadinone acetate as a treatment maneuver for safer operations].
Topics: Aged; Chlormadinone Acetate; Humans; Laser Coagulation; Male; Middle Aged; Preoperative Care; Prostate; Prostatic Hyperplasia; Transurethral Resection of Prostate | 2005 |
Preoperative administration of chlormadinone acetate reduces blood loss associated with transurethral resection of the prostate: a prospective randomized study.
Topics: Aged; Androgen Antagonists; Blood Loss, Surgical; Chlormadinone Acetate; Humans; Male; Preoperative Care; Prospective Studies; Prostatic Hyperplasia; Regression Analysis; Statistics, Nonparametric; Transurethral Resection of Prostate | 2005 |
[Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
Topics: Aged; Androgen Antagonists; Animals; Chlormadinone Acetate; Clinical Trials as Topic; Humans; Hydroxytestosterones; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats | 1980 |
[The effect of TZP-4238, an anti-androgen drug, on renal function].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Prostatic Hyperplasia | 1994 |
[Study of clinical usefulness of an antiandrogen, TZP-4238, as a drug for treatment of benign prostatic hypertrophy--its influence on sexual function].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Sex; Sexual Behavior | 1994 |
[Clinical study of TZP-4238 on patients with benign prostatic hypertrophy--with special reference to urodynamics].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Middle Aged; Prostatic Hyperplasia; Urinary Bladder Neck Obstruction; Urodynamics | 1994 |
[Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].
Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Humans; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Time Factors; Urethra; Urodynamics | 1993 |
A comparison of transurethral resection of the prostate and medical treatment for the patient with moderate symptoms of benign prostatic hyperplasia.
Topics: Chlormadinone Acetate; Follow-Up Studies; Humans; Male; Pilot Projects; Prospective Studies; Prostate; Prostatic Hyperplasia | 1996 |
Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia. The Kobe University YM617 Study Group.
Topics: Adrenergic alpha-Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Progesterone Congeners; Prostatectomy; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin; Urodynamics | 1996 |
[A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Drug Therapy, Combination; Humans; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urodynamics | 2000 |
[Clinical effects of chlormadinone acetate (CMA) on human benign prostatic hypertrophy--comparative study with hexestrol by a double blind trial (author's transl)].
Topics: Aged; Chlormadinone Acetate; Clinical Trials as Topic; Double-Blind Method; Hexestrol; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1979 |
[Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate Part I: Nocturnal penile tumescence monitoring].
Topics: Aged; Allylestrenol; Chlormadinone Acetate; Clinical Trials as Topic; Double-Blind Method; Estrenes; Humans; Male; Middle Aged; Monitoring, Physiologic; Multicenter Studies as Topic; Penile Erection; Prostatic Hyperplasia; Sleep; Testosterone; Urination | 1990 |
[Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate. Part II: Self-assessment questionnaire method].
Topics: Adult; Aged; Allylestrenol; Chlormadinone Acetate; Clinical Trials as Topic; Double-Blind Method; Estrenes; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prostatic Hyperplasia; Self-Assessment; Sex; Surveys and Questionnaires | 1990 |
[Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method].
Topics: Administration, Oral; Aged; Allylestrenol; Chlormadinone Acetate; Clinical Trials as Topic; Double-Blind Method; Estrenes; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1986 |
48 other study(ies) available for chlormadinone acetate and Prostatic Hyperplasia
| Article | Year |
|---|---|
Prostatic fluid composition and semen quality in dogs with benign prostatic hyperplasia undergoing treatment with osaterone acetate.
Topics: Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Male; Prostatic Hyperplasia; Semen Analysis | 2022 |
DIAGNOSIS AND MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA IN A PIED TAMARIN (SAGUINUS BICOLOR).
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Male; Monkey Diseases; Prostatic Hyperplasia; Saguinus | 2016 |
[Transient, secondary hypoadrenocorticism after treatment with delmadinone acetate (Tardastrex®) in a two year old male dog].
Topics: Adrenal Insufficiency; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Glucocorticoids; Male; Prednisolone; Prostatic Hyperplasia; Treatment Outcome | 2016 |
Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Dutasteride; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Treatment Outcome | 2017 |
[Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone | 2011 |
Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Humans; Male; Middle Aged; Nonlinear Dynamics; Prostate-Specific Antigen; Prostatic Hyperplasia; Retrospective Studies | 2006 |
Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration.
Topics: Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Meningeal Neoplasms; Meningioma; Neoplasm Regression, Spontaneous; Progesterone; Prostatic Hyperplasia | 2008 |
Binding of chlormadinone acetate to cytosol from human benign prostatic hypertrophy.
Topics: Androgen Antagonists; Chlormadinone Acetate; Cytosol; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia | 1980 |
[Clinical evaluation of chlormadinone acetate (CMA) in benign prostatic hypertrophy (author's transl)].
Topics: Aged; Chlormadinone Acetate; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1981 |
[Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
Topics: Aged; Chlormadinone Acetate; Drug Evaluation; Humans; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Tomography; Ultrasonography | 1983 |
Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Chlormadinone Acetate; Contraceptives, Oral; Dihydrotestosterone; Disease Models, Animal; Dogs; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Ultrasonography | 1995 |
[Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism].
Topics: Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Gestonorone Caproate; Humans; Lipid Metabolism; Lipids; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Nandrolone; Prostatic Hyperplasia | 1994 |
Histological evaluation of benign prostatic hyperplasia treated by long-term administration of chlormadinone acetate (CMA).
Topics: Aged; Biomarkers; Chlormadinone Acetate; Drug Administration Schedule; Humans; Immunohistochemistry; Male; Middle Aged; Prostatic Hyperplasia | 1994 |
Inhibition of steroid-induced prostatic hyperplasia in rats by treatment with anti-androgen (TZP-4238).
Topics: Androgen Antagonists; Animals; Bromodeoxyuridine; Chlormadinone Acetate; Drug Interactions; Estradiol; Glutathione Peroxidase; Male; Orchiectomy; Organ Size; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar; Receptors, Androgen; Testosterone | 1993 |
Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
Topics: Administration, Oral; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Male; Prostatic Hyperplasia | 1995 |
Transurethral microwave thermotherapy for benign prostatic hyperplasia: patient characteristics in good and poor responders.
Topics: Allylestrenol; Chlormadinone Acetate; Dose-Response Relationship, Radiation; Humans; Hyperthermia, Induced; Male; Microwaves; Pressure; Prostatic Hyperplasia; Treatment Outcome; Urination | 1994 |
Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
Topics: Aging; Animals; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Implants; Luteinizing Hormone; Male; Progesterone Congeners; Prostate; Prostatic Hyperplasia; Semen; Sperm Motility; Spermatozoa; Testosterone; Time Factors | 1995 |
Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Topics: Administration, Oral; Androstenedione; Animals; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Reference Values | 1993 |
Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Topics: Animals; Biopsy; Chlormadinone Acetate; Contraceptives, Oral, Synthetic; Dog Diseases; Dogs; Drug Implants; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Semen; Seminiferous Tubules; Testis | 1995 |
Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
Topics: Administration, Oral; Androgen Antagonists; Animals; Chlormadinone Acetate; Dogs; Drug Implants; Estradiol; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Testis; Testosterone | 1998 |
Effects of delmadinone acetate on pituitary-adrenal function, glucose tolerance and growth hormone in male dogs.
Topics: Adrenal Cortex; Adrenal Insufficiency; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Blood Glucose; Chlormadinone Acetate; Contraceptive Agents; Dog Diseases; Dogs; Glucose Intolerance; Glucose Tolerance Test; Growth Hormone; Hydrocortisone; Insulin; Male; Pituitary-Adrenal System; Progestins; Prospective Studies; Prostatic Hyperplasia; Radioimmunoassay; Random Allocation | 1998 |
[Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only].
Topics: Adrenergic alpha-Antagonists; Aged; Chlormadinone Acetate; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Progesterone Congeners; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin | 1998 |
Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dogs; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen | 1998 |
Ultrastructural study in canine prostatic hyperplasia--effect of antiandrogen.
Topics: Animals; Chlormadinone Acetate; Dogs; Male; Progesterone Congeners; Prostate; Prostatic Hyperplasia | 1998 |
Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
Topics: Androgen Antagonists; Androgens; Animals; Chlormadinone Acetate; Dogs; Immunohistochemistry; Male; Progesterone Congeners; Prostatic Hyperplasia; Receptors, Androgen | 1999 |
Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Atrophy; Chlormadinone Acetate; Dogs; Immunohistochemistry; Isoenzymes; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen | 2000 |
Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Androstadienes; Animals; Aromatase Inhibitors; Chlormadinone Acetate; Dihydrotestosterone; Dogs; Enzyme Inhibitors; Estradiol; Estradiol Congeners; Female; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Rabbits; Rats; Receptors, Estrogen; Testosterone | 2000 |
Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Androgen Antagonists; Animals; Chlormadinone Acetate; Dogs; Luteinizing Hormone; Male; Organ Size; Pituitary Gland, Anterior; Prostate; Prostatic Hyperplasia; Testis | 2000 |
Regression of prostatic hypertrophy by osaterone acetate in dogs.
Topics: Administration, Oral; Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Luteinizing Hormone; Male; Prostatic Hyperplasia; Testosterone | 2000 |
[Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].
Topics: Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Drug Administration Schedule; Humans; Male; Middle Aged; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Hyperplasia | 2000 |
Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Topics: Androgen Antagonists; Animals; Apoptosis; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Finasteride; Male; Prostate; Prostatic Hyperplasia; Testosterone | 2001 |
Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Dog Diseases; Dogs; Luteinizing Hormone; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Semen; Sperm Count; Testosterone | 2001 |
The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Androgen Antagonists; Animals; Chlormadinone Acetate; Dogs; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Luteinizing Hormone; Male; Organ Size; Pituitary Gland; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testis | 2001 |
Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Topics: Androgen Antagonists; Animals; Apoptosis; Atrophy; Chlormadinone Acetate; Dogs; Male; Progesterone Congeners; Prostate; Prostatic Hyperplasia | 2001 |
[The mechanism of antiandrogenic action of chlormadinone acetate (author's transl)].
Topics: Aged; Androgen Antagonists; Animals; Chlormadinone Acetate; Humans; Male; Prostatic Hyperplasia; Rats | 1977 |
Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Chlormadinone Acetate; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Male; Organ Size; Oxidoreductases; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Ultrasonography | 1992 |
Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
Topics: Animals; Chlormadinone Acetate; Dogs; Female; Immunohistochemistry; Male; Organ Size; Pituitary Gland; Prostatic Hyperplasia; Testis; Testosterone | 1992 |
[Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Drug Evaluation; Humans; Male; Middle Aged; Organ Size; Prostate; Prostatic Hyperplasia; Ultrasonography; Urination | 1990 |
[Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
Topics: Administration, Oral; Androgen Antagonists; Chlormadinone Acetate; Humans; Injections, Intramuscular; Male; Nandrolone; Prostate; Prostatic Hyperplasia; Ultrasonography | 1990 |
Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
Topics: Administration, Oral; Androgen Antagonists; Androstane-3,17-diol; Animals; Chlormadinone Acetate; Dogs; Estradiol; Male; Microscopy, Electron; Orchiectomy; Organ Size; Prostatic Hyperplasia | 1990 |
[Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results].
Topics: Administration, Oral; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Drug Administration Schedule; Drug Evaluation; Gestonorone Caproate; Humans; Male; Prostatic Hyperplasia | 1991 |
[Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
Topics: Administration, Oral; Aged; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Humans; Injections, Intramuscular; Male; Nandrolone; Prostatic Hyperplasia | 1991 |
[Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].
Topics: Administration, Oral; Androgen Antagonists; Chlormadinone Acetate; Drug Evaluation; Follow-Up Studies; Humans; Male; Organ Size; Prostate; Prostatic Hyperplasia; Ultrasonography | 1988 |
[Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy].
Topics: Administration, Oral; Chlormadinone Acetate; Ethisterone; Ethynodiol Diacetate; Humans; Hydroxyprogesterones; Male; Medroxyprogesterone; Megestrol; Norethindrone; Norethynodrel; Progesterone; Progestins; Prostatic Hyperplasia | 1970 |
[Studies of mechanisms of the action of androgens on prostate. 3. Anti-androgenic effect of gestagenic compounds and treatment of benign prostatic hypertrophy with chlormadinone acetate].
Topics: Acetates; Aged; Androgen Antagonists; Animals; Chlormadinone Acetate; Humans; Hydroxycorticosteroids; Ketosteroids; Male; Middle Aged; Pregnanes; Prostate; Prostatic Hyperplasia; Rats; Testosterone | 1972 |
[Hypertrophy of the prostatic gland].
Topics: Chlormadinone Acetate; Humans; Male; Prostatic Hyperplasia | 1974 |
Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
Topics: 17-Ketosteroids; Adrenal Glands; Animals; Carcinoma; Chlormadinone Acetate; Estrogens; Gonadotropins, Pituitary; Gonads; Hydroxyprogesterones; Luteinizing Hormone; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1967 |
Therapy with progestational agents in advanced benign prostatic hypertrophy.
Topics: Aged; Blood Urea Nitrogen; Chlormadinone Acetate; Follow-Up Studies; Humans; Hydroxyprogesterones; Kidney Function Tests; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Time Factors; Urinary Catheterization; Urination Disorders | 1969 |